Skip to Main Content

Author Details

Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
2008
80
21
PMIDPaper TitleJournal TitlePublished Year
34742620Human papillomavirus-related multiphenotypic sinonasal carcinoma.Auris Nasus Larynx2023
36214668Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung Cancer.Mol Cancer Res2023
36369892Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectum.Cancer Sci2023
36201027The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy.J Cancer Res Clin Oncol2023
36127822Dirty necrosis in renal cell carcinoma is associated with NETosis and systemic inflammation.Cancer Med2023
34611830Significance of chemotherapy-free interval and tumor regression grade in patients with recurrent esophageal squamous cell carcinoma receiving chemotherapy with fluorouracil and platinum after esophagectomy following preoperative chemotherapy.Esophagus2022
35383171Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.Nat Commun2022
35386167Adult T-Cell Leukemia/Lymphoma With Extranodal Involvement of the Hypopharynx.Cureus2022
36704363Tumor-identification method for predicting recurrence of early-stage lung adenocarcinoma using digital pathology images by machine learning.J Pathol Inform2022
36456131Immunohistochemical Analysis of Common Cancer Antigens in Head and Neck Squamous Cell Carcinoma.Anticancer Res2022
36379125The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.Lung Cancer2022
35181964Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.Cancer Sci2022
35215338Evaluation of Fluorescence Intensity and Antitumor Effect Using Real-Time Imaging in Photoimmunotherapy.Pharmaceuticals (Basel)2022
35143092Pathologic method for extracting good prognosis group in triple-negative breast cancer after neoadjuvant chemotherapy.Cancer Sci2022
3502326818F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.Cancer Sci2022
32870526Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model.J Gastroenterol Hepatol2021
33811275Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma.J Cancer Res Clin Oncol2021
33503282An autopsy case of aortic dissection due to giant cell arteritis.Pathol Int2021
33916417Integrative RNA-Seq and H3 Trimethylation ChIP-Seq Analysis of Human Lung Cancer Cells Isolated by Laser-Microdissection.Cancers (Basel)2021
35127323A case of Epstein-Barr virus-positive mucocutaneous ulcer of the hypopharynx: a mimicker of hypopharyngeal squamous cell carcinoma.Int Cancer Conf J2021
34611548Activation of a Cryptic Splice Site of <i>GFAP</i> in a Patient With Adult-Onset Alexander Disease.Neurol Genet2021
34788078Assessing therapy response in patient-derived xenografts.Sci Transl Med2021
31130350Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.J Pediatr Surg2020
31688631Urgent Proton Beam Therapy With Interinstitutional Transfer for Patients With Intracranial Rhabdomyosarcoma: Report of 3 Cases.J Pediatr Hematol Oncol2020
32341852Polarimetric second-harmonic generation microscopy of the hierarchical structure of collagen in stage I-III non-small cell lung carcinoma.Biomed Opt Express2020
30568142A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression.Intern Med2019
31682048Dickkopf-related protein 3 promotes cell adhesion and invasion during progression of lung adenocarcinoma.Pathol Int2019
31472337A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary site.Lung Cancer2019
30978569Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.Neoplasia2019
31143076Recurrent renal cell carcinoma leading to a misdiagnosis of polycystic liver disease: A case report.World J Gastroenterol2019
30728155Stratifin Inhibits SCF<sup>FBW7</sup> Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis.Clin Cancer Res2019
30899432DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma.Oncotarget2019
30632058Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis.Int J Hematol2019
28939555A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate (LDC).Mol Cancer Ther2018
30106638Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.J Clin Oncol2018
29887244Case report of three EGFR TKI naïve lung adenocarcinoma containing double EGFR mutations (L858R/T790M or Exon 19 Deletion/T790M); Comparing genetic information and histology.Pathol Res Pract2018
29880877Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.Oncogene2018
30089591The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.Lung Cancer2018
30197580Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors.Rep Pract Oncol Radiother2018
29952292Multiple haemangiomas in TAFRO syndrome with atypical features of glomeruloid and epithelioid haemangiomas.Eur J Dermatol2018
30320419High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.Pathol Int2018
29751134Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.J Thorac Oncol2018
29572010Heterotopic production of ceruloplasmin by lung adenocarcinoma is significantly correlated with prognosis.Lung Cancer2018
29431240The prognostic significance of N-myc downregulated gene 1 in lung adenocarcinoma.Pathol Int2018
29451344A case of microscopic, multiple sclerosing pneumocytoma.Pathol Int2018
29154469Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features.Pathol Int2018
27750381Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Int J Cancer2017
28464908A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.Breast Cancer Res2017
29156674Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts.Oncotarget2017
29027312Cyclophilin A expression and its prognostic significance in lung adenocarcinoma.Pathol Int2017
  • 1 - 50 of 80

Recommended Authors

Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 7
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Shaolei Li
Peking University Cancer Hospital & Institute
Career Start Year 2012
Number of shared co-authors 0
Shuhua Li
The First Affiliated Hospital, Sun Yat-sen University
Career Start Year 2012
Number of shared co-authors 1
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Jun Huang
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2006
Number of shared co-authors 0
Li Liu
Central South University
Career Start Year 2006
Number of shared co-authors 0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Yue Yang
Peking University Cancer Hospital
Career Start Year 2005
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 2
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 0
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 1
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 1
Prudence A Russell
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 5
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 5
Liyan Xue
Xuzhou Central Hospital
Career Start Year 1996
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Jianxing He
Guangzhou Medical University, First Hospital
Career Start Year 1994
Number of shared co-authors 1
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 1
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 2

Collaborators

Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 22
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 11
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 9
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Ming Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Lucia Kim
Inha University Hospital
Co-authored papers 6
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Michael F Moran
Hospital for Sick Children, University of Toronto
Co-authored papers 5
Paul Taylor
Hospital for Sick Children
Co-authored papers 5
Dennis Wang
Sheffield Institute of Translational Neuroscience, University of Sheffield
Co-authored papers 5
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Nadeem Moghal
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Thomas K Waddell
Toronto General Hospital
Co-authored papers 4
Vibha Raghavan
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Jiefei Tong
Hospital for Sick Children
Co-authored papers 3
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers 3
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 3
Ghassan Allo
Henry Ford Hospital
Co-authored papers 3
Lei Li
Hospital for Sick Children
Co-authored papers 2
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Co-authored papers 2
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers 2
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Sharon Lee
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Yuhong Wei
Rosalind and Morris Goodman Cancer Institute, McGill University
Co-authored papers 2
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 2
Zhuo Chen
The First Hospital of Lanzhou University
Co-authored papers 2
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Co-authored papers 2
Shaf Keshavjee
University Health Network, University Health Network and University of Toronto
Co-authored papers 2
Vladimir Ignatchenko
Margaret Cancer Center
Co-authored papers 2
Release 1.2